Treatment Innovations

Bridging the Gap: AbbVie’s Maviret and the Complex Real-World Reality of Hepatitis C Elimination

• Treatment Innovations

Bridging the Gap: AbbVie’s Maviret and the Complex Real-World Reality of Hepatitis C Elimination

Ali Ikhwan September 4, 2026

Despite the existence of highly effective oral antivirals for over a decade, Hepatitis C (HCV) remains a...

Read More Read more about Bridging the Gap: AbbVie’s Maviret and the Complex Real-World Reality of Hepatitis C Elimination

Regulatory Scrutiny Intensifies: Boston Scientific Recalls SCS Lead Kits Amid Wave of Industry-Wide Litigation

• Treatment Innovations

Regulatory Scrutiny Intensifies: Boston Scientific Recalls SCS Lead Kits Amid Wave of Industry-Wide Litigation

Ali Ikhwan September 4, 2026

The medical technology sector is currently navigating a period of heightened regulatory scrutiny and legal turbulence. At...

Read More Read more about Regulatory Scrutiny Intensifies: Boston Scientific Recalls SCS Lead Kits Amid Wave of Industry-Wide Litigation

AbbVie’s Etentamig Challenges Multiple Myeloma Treatment Landscape with Superior Safety Profile

• Treatment Innovations

AbbVie’s Etentamig Challenges Multiple Myeloma Treatment Landscape with Superior Safety Profile

Ammar Sabilarrohman September 4, 2026

By Jonathan Gardner Published September 4, 2026 In the rapidly evolving arena of hematologic oncology, the pursuit...

Read More Read more about AbbVie’s Etentamig Challenges Multiple Myeloma Treatment Landscape with Superior Safety Profile

Globus Medical Expands Surgical Precision: Excelsius3D Platform Secures CE Mark for European Markets

• Treatment Innovations

Globus Medical Expands Surgical Precision: Excelsius3D Platform Secures CE Mark for European Markets

Jia Lissa September 4, 2026

Executive Summary: A New Era for European Operating Theatres Globus Medical, a global leader in musculoskeletal implant...

Read More Read more about Globus Medical Expands Surgical Precision: Excelsius3D Platform Secures CE Mark for European Markets

Metabolic Stability: The Defining Frontier for the Future of Multifunctional Peptides

• Treatment Innovations

Metabolic Stability: The Defining Frontier for the Future of Multifunctional Peptides

Nana Muazin September 4, 2026

The pharmaceutical landscape is currently witnessing a renaissance in peptide therapeutics. Historically sidelined in favor of small...

Read More Read more about Metabolic Stability: The Defining Frontier for the Future of Multifunctional Peptides

The Dawn of the Bispecific Era: Ivonescimab Challenges the Oncology Status Quo

• Treatment Innovations

The Dawn of the Bispecific Era: Ivonescimab Challenges the Oncology Status Quo

Neng Nana September 4, 2026

By Jonathan Gardner | Published Sept. 3, 2026 The landscape of lung cancer treatment, already fundamentally reshaped...

Read More Read more about The Dawn of the Bispecific Era: Ivonescimab Challenges the Oncology Status Quo

Illuminating the Invisible: How FINICI is Revolutionizing Sub-Cellular Imaging

• Treatment Innovations

Illuminating the Invisible: How FINICI is Revolutionizing Sub-Cellular Imaging

Azzam Bilal Chamdy September 4, 2026

For decades, the field of cell biology has been constrained by a persistent optical paradox. Scientists have...

Read More Read more about Illuminating the Invisible: How FINICI is Revolutionizing Sub-Cellular Imaging

Navigating the Future of MedTech: GlobalData Healthcare’s Q4 Strategic Outlook

• Treatment Innovations

Navigating the Future of MedTech: GlobalData Healthcare’s Q4 Strategic Outlook

Reynand Wu September 4, 2026

As the industry transitions out of the summer season and into the final quarter of 2026, the...

Read More Read more about Navigating the Future of MedTech: GlobalData Healthcare’s Q4 Strategic Outlook

GSK Bets Big on Next-Gen Oncology: The $1.3 Billion Hutchmed Collaboration

• Treatment Innovations

GSK Bets Big on Next-Gen Oncology: The $1.3 Billion Hutchmed Collaboration

Rifan Muazin September 4, 2026

By Delilah Alvarado Published September 3, 2026 In a significant strategic move to solidify its position in...

Read More Read more about GSK Bets Big on Next-Gen Oncology: The $1.3 Billion Hutchmed Collaboration

Heartvue.Proton Secures FDA Clearance: A New Era for AI-Driven Cardiovascular Imaging

• Treatment Innovations

Heartvue.Proton Secures FDA Clearance: A New Era for AI-Driven Cardiovascular Imaging

Jia Lissa September 3, 2026

In a significant leap forward for diagnostic cardiology, Tennessee-based medical technology firm Heartvue.ai has announced that its...

Read More Read more about Heartvue.Proton Secures FDA Clearance: A New Era for AI-Driven Cardiovascular Imaging